Compounds > tryptophan

tryptophan and Refractory Depression

tryptophan has been researched along with Refractory Depression in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khanam, R; Thomas, J; Vohora, D1
Hashimoto, K; Shi, JY; Wang, N; Yang, C; Yang, JJ; Yu, HY1
Babic, S; Bermudez, I; Franklin, M; Hlavacova, N; Jezova, D1
Bhat, M; Erhardt, S; Frye, MA; Johansson, AG; Jungholm, O; Landén, M; Samuelsson, M; Schuppe-Koistinen, I; Schwieler, L; Sellgren, CM1
Bottrel, N; Corum, DG; Drevets, WC; Fiehn, O; Kaddurah-Daouk, R; Motsinger-Reif, A; Rotroff, DM; Salvadore, G; Singh, J1

Other Studies

5 other study(ies) available for tryptophan and Refractory Depression

ArticleYear
Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
    Psychiatry research, 2017, Volume: 258

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depression; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Interleukin-1beta; Interleukin-6; Kynurenine; Male; Mice; Olanzapine; Serotonin; Stress, Psychological; Swimming; Tryptophan; Venlafaxine Hydrochloride

2017
Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
    Biological psychiatry, 2015, Feb-01, Volume: 77, Issue:3

    Topics: Antidepressive Agents; Biomarkers, Pharmacological; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Inpatients; Interleukin-1beta; Interleukin-6; Ketamine; Kynurenine; Psychiatric Status Rating Scales; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha

2015
Pineal Melatonin in a Sub-chronic Tryptophan Depletion Female Rat Model of Treatment-resistant Depression.
    Pharmacopsychiatry, 2015, Volume: 48, Issue:4-5

    Topics: Aldosterone; Animals; Corticosterone; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Female; Melatonin; Norepinephrine; Pineal Gland; Rats; Serotonin; Tryptophan

2015
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Journal of neuroinflammation, 2016, Feb-29, Volume: 13, Issue:1

    Topics: Adult; Chromatography, High Pressure Liquid; Cohort Studies; Cytokines; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Electroconvulsive Therapy; Female; Humans; Interleukin-6; Kynurenine; Luminescence; Male; Metabolic Networks and Pathways; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Tryptophan; Young Adult

2016
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
    Translational psychiatry, 2016, 09-20, Volume: 6, Issue:9

    Topics: Adult; Arginine; Citrulline; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Indoleacetic Acids; Infusions, Intravenous; Ketamine; Male; Metabolomics; Methionine; Middle Aged; Ornithine; Phenotype; Phospholipids; Tryptophan; Urea

2016